Trial intelligence / Profile preview

Effect of common figs and almond syrup, sweet almond syrup and methylphenidate in ADHD

IRCT20220406054433N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by Iran University of Medical Sciences. Started Apr 2022; status: completed.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)

Beyond the preview

Go deeper on IRCT20220406054433N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220406054433N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call